Skip to content
Lower risk Drug recall · FDA · Published January 22, 2024

IntegraDose Vasopressin Syringes: Sub-potent Drug Risk

IntegraDose recalls specific vasopressin syringes due to potential loss of potency over time. These are compounded drugs for medical use only.

🇺🇸 FDA recall #D-0325-2024DrugIntegraDose ›
Take action

Contact the company

Recalling firmIntegraDose Compounding Services LLC719 Kasota Ave Se · Minneapolis, MN 55414-2842
✎ GovInfoNow plain-language explainer

IntegraDose is recalling certain vasopressin syringes because they may lose potency after the expiration date. This could affect medical treatment effectiveness if used beyond the labeled date. Read more at govinfonow.com/recall/32853-integradose-vasopressin-syringes-sub-potent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32853-integradose-vasopressin-syringes-sub-potent-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0325-2024

Cite this page

“IntegraDose Vasopressin Syringes: Sub-potent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32853-integradose-vasopressin-syringes-sub-potent-drug-risk. Based on FDA recall #D-0325-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0325-2024%22&limit=1).

The FDA announced on Jan. 22, 2024, that IntegraDose Compounding Services LLC is recalling Vasopressin sterile syringes due to sub-potent drug risks. Owners should stop using the product immediately.

How to tell if you have it

  • Brand: IntegraDose
  • Product: Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe
  • NDC: 71139-0190-1
  • Lot #s: 20230929VAS-2 (Exp. 02/29/2024), 20231004VAS-2 (Exp. 04/01/2024), 20231010VAS-2 (Exp. 04/07/2024), 20231013VAS-2 (Exp. 04/10/2024)
  • Distribution: MN
  • Units affected: 1,299 syringes

The hazard

The recall addresses the failure to maintain potency through the duration of the labeled expiration or beyond-use date. This sub-potent drug risk may affect the efficacy of the vasopressin injection.

Context

GovInfoNow's records show IntegraDose Compounding Services LLC has had six other recalls since Sept. 17, 2021. Recent similar recalls include an IntegraDose Vasopressin recall on May 18, 2026, and an IntegraDose Fentanyl Citrate recall on May 12, 2026. Other recent recalls of similar products include a Kirkman VasoCaine Spray recall (Feb. 18, 2026), a Baxter Vasopressin Injection recall (Aug. 6, 2026), and a Somerset Therapeutics Dexamethasone Injection recall (Feb. 4, 2026).

How to tell if you have this one

Check for lot numbers: 20230929VAS-2, 20231004VAS-2, 20231010VAS-2, or 20231013VAS-2. These syringes were compounded for medical use only and sold with specific expiration dates.

  • Brand
    IntegraDose
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Expiration Date

    Verify the expiration date on the syringe label. If it has expired, do not use the medication.

Where it went and when

Where it was distributed

Distributed in Minnesota.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “MN” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Minnesota.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Jan 22, 202412. FDA classified it Class II: Feb 15, 202423. Published in FDA’s Enforcement Report: Feb 21, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Who should contact for help?

Contact IntegraDose Compounding Services LLC at 719 Kasota Ave SE, Minneapolis, MN for further assistance.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0325-2024 (January 22, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0325-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA